Institutional investors hold a majority ownership of MYL through the 91.24% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2014, these large investors purchased a net $1.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STRATEGIC ADVISERS, INC. Bought 72.4 Thousand shares of Mylan Inc